Sep 26, 2018
Aridis Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference
Jun 07, 2018
Microbiotix presents new data at the ASM Microbe 2018 Conference
May 30, 2018
Geom Therapeutics To Present Data From Antibiotic Drug Development Programs At ASM Microbe
Apr 03, 2018
Nosocomial Vaccine Corporation Announces Presentation on Multivalent Vaccine for Gram-Negative Pathogens, including Multiple Antibiotic-Resistant Strains at World Vaccine Conference
Mar 14, 2018
Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase Development Award to $US 5M
Mar 05, 2018
MicuRx Announces Funding from CARB-X for Innovative Polymyxin Antibiotic MRX-8
Feb 27, 2018
Aridis Pharmaceuticals Forms Subsidiary to Develop and Market its Monoclonal Antibody Therapies in China
Feb 13, 2018
Antibiotics developer Octagon Therapeutics closes financing, adds thought leaders
Jan 03, 2018
Novoclem announces issuance of patent covering a core technology underlying its Cystic Fibrosis therapeutic development program
Jan 03, 2018
Locus Biosciences and IDbyDNA Partner to Develop Companion Diagnostic Test for Pseudomonas aeruginosa Infection
Dec 05, 2017
Breakthrough Evidence on Vomaris Bioelectric Technology's Impact on Wound Biofilm Infection
Nov 07, 2017
Novoclem Therapeutics, Inc. Receives QIDP Status for Its Lead Inhaled Antimicrobial Drug Candidate
Nov 01, 2017
Novoclem presents promising new data at the North America Cystic Fibrosis Conference on November 2, 2017
Oct 18, 2017
Positive Developments From Clinical Studies and FDA Approvals Pushing Biotech Stocks to New Highs
Oct 04, 2017
Shionogi Presents Positive Clinical Efficacy Trial Results And In Vitro Data On Cefiderocol, At IDWeek 2017
Oct 04, 2017
New Nitric Oxide Treatment Eradicates Emerging 'Superbugs'
Sep 28, 2017
TAXIS Pharmaceuticals to Present Pipeline Update at Biotech in Europe Forum
Sep 28, 2017
Shionogi To Highlight Research On Cefiderocol (S-649266), A Siderophore Cephalosporin, And S-033188, A Cap-Dependent Endonuclease Inhibitor For Treatment Of Influenza, At IDWeek 2017
Sep 27, 2017
Pall Leaps Forward with Patient Care Focus Following US Food & Drug Administration 510(k) Clearance for QPoint® Water Filter Capsules
Sep 27, 2017
Geom Therapeutics to Develop and Commercialize LegoChem Biosciences' Novel Beta Lactamase Inhibitors For Treating Gram-Negative Infections